Tirbanibulin 1% Ointment in field therapy for the treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis on the face or scalp in adults
- Conditions
- L57.0Actinic keratosis
- Registration Number
- DRKS00027120
- Lead Sponsor
- Almirall Hermal GmbH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 549
Inclusion Criteria
Any person who is at least 18 years old, has signed and dated this informed consent form and for whom treatment with Klisyri® 10 mg/g ointment has been planned by the treating physician may participate in this study.
Exclusion Criteria
Patients who are not eligible for treatment with Klisyri® in accordance with the approved product information.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method - Efficacy of Klisyri® in routine practice by recording the 100% clearance rate of AK lesions in the treatment area at the end of the response period (visit 3, planned day 57)<br>- Safety and tolerability of Klisyri® in routine practice
- Secondary Outcome Measures
Name Time Method among others:<br>- Patient reported outcomes (AKQoL, PGII, cosmetic rating scale).<br>- Patient's future treatment preference (willingness to repeat treatment with Klisyri®).